Ninepoint Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500,000
Closed -$3.06M 184
2025
Q4
$3.06M Hold
500,000
0.34% 46
2025
Q3
$2.59M Buy
+500,000
New +$2.87M 0.34% 38
2024
Q3
Sell
-5,000,000
Closed -$51.8M 107
2024
Q2
$51.8M Buy
+5,000,000
New +$54.8M 4.92% 7
2018
Q2
Sell
-375,000
Closed -$6.57M 100
2018
Q1
$6.57M Buy
+375,000
New +$7.83M 0.49% 33
2017
Q4
Sell
-450,000
Closed -$9.42M 130
2017
Q3
$9.42M Buy
+450,000
New +$8.29M 0.66% 33

Other funds holding PTEN

Ninepoint Partners's PTEN Position: Q1 2026 in Review

Ninepoint Partners sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 500,000 shares — an estimated $3.06M sold.

Ninepoint Partners first reported a position in PTEN in Q3 2017 and held it in 5 quarters. The position peaked at $51.8M in Q2 2024. 414 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Ninepoint Partners reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
  • Ninepoint Partners sold 500,000 Patterson-UTI shares in Q1 2026, an estimated $3.06M.
  • Ninepoint Partners first reported a position in Patterson-UTI in Q3 2017 and held it in 5 quarters.
  • Ninepoint Partners's Patterson-UTI position peaked at $51.8M in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Ninepoint Partners's 13F filing for Q1 2026, filed 11 Aug 2026.